Home - Products - Angiogenesis - CDK - Eciruciclib

Eciruciclib

CAS No. 1868086-40-1

Eciruciclib( —— )

Catalog No. M28496 CAS No. 1868086-40-1

Eciruciclib is an inhibitor of CDK with antitumor properties.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	312	Get Quote
10MG	500	Get Quote
25MG	807	Get Quote
50MG	1107	Get Quote
100MG	1485	Get Quote
200MG	Get Quote	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Eciruciclib
Note

Research use only, not for human use.
Brief Description

Eciruciclib is an inhibitor of CDK with antitumor properties.
Description

Eciruciclib is an inhibitor of CDK with antitumor properties.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Angiogenesis
Target

CDK
Recptor

——
Research Area

——
Indication

——

Chemical Information

CAS Number

1868086-40-1
Formula Weight

488.6
Molecular Formula

C27H33FN8
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 2 mg/mL (4.09 mM)
SMILES

CC(C1=C2C=C(C3=NC(NC4=NC=C(CN5CCN(CC)CC5)C=C4)=NC=C3F)C=CC2=NN1C)C
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

RO5454291

RO5258638 is a small molecule inhibitor of CDK5-p25 protein-protein interaction with IC50 of 1.39 uM.
XY028-140

XY028-140 is a selective CDK4/CDK6 degrade and inhibits both CDK4/6 expression and activity in cancer cells. XY028-140 is a PROTAC connected by ligands for Cereblon and CDK.
Bohemine

Bohemine is a cyclin-dependent kinase inhibitor.

Sign In Join Free